OAM
CRL icon

Oxford Asset Management’s Charles River Laboratories CRL Stock Holding History

Oxford Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,504
Closed -$392K – 546
2025
Q3 		$392K Buy
+2,504
New +$398K 0.13% 279
2020
Q1 		– Sell
-5,377
Closed -$821K – 456
2019
Q4 		$821K Buy
5,377
+1,332
+33% +$184K 0.02% 978
2019
Q3 		$535K Buy
+4,045
New +$542K 0.01% 1235
2019
Q2 		– Sell
-6,253
Closed -$908K – 1744
2019
Q1 		$908K Sell
6,253
-16,983
-73% -$2.23M 0.02% 970
2018
Q4 		$2.63M Buy
23,236
+15,233
+190% +$1.91M 0.07% 351
2018
Q3 		$1.07M Sell
8,003
-16,262
-67% -$2.01M 0.02% 976
2018
Q2 		$2.7M Buy
24,265
+8,563
+55% +$926K 0.05% 480
2018
Q1 		$1.68M Buy
15,702
+2,366
+18% +$255K 0.04% 670
2017
Q4 		$1.46M Sell
13,336
-35,516
-73% -$3.86M 0.03% 739
2017
Q3 		$5.28M Buy
48,852
+3,695
+8% +$380K 0.1% 213
2017
Q2 		$4.57M Buy
45,157
+10,532
+30% +$969K 0.09% 230
2017
Q1 		$3.12M Buy
34,625
+16,209
+88% +$1.38M 0.08% 273
2016
Q4 		$1.4M Sell
18,416
-8,862
-32% -$673K 0.05% 405
2016
Q3 		$2.27M Sell
27,278
-25,312
-48% -$2.12M 0.07% 380
2016
Q2 		$4.34M Buy
52,590
+16,676
+46% +$1.37M 0.14% 176
2016
Q1 		$2.73M Buy
35,914
+27,556
+330% +$2.04M 0.08% 303
2015
Q4 		$675K Buy
8,358
+4,679
+127% +$337K 0.02% 621
2015
Q3 		$234K Buy
+3,679
New +$264K 0.01% 569
2015
Q2 		– Sell
-46,743
Closed -$3.71M – 675
2015
Q1 		$3.71M Buy
+46,743
New +$3.45M 0.09% 243
2014
Q4 		– Sell
-48,300
Closed -$2.92M – 724
2014
Q3 		$2.92M Sell
48,300
-12,446
-20% -$712K 0.07% 295
2014
Q2 		$3.23M Buy
+60,746
New +$3.33M 0.1% 280
2014
Q1 		– Sell
-175,047
Closed -$9.28M – 660
2013
Q4 		$9.28M Sell
175,047
-19,552
-10% -$982K 0.23% 117
2013
Q3 		$9M Buy
194,599
+98,287
+102% +$4.51M 0.2% 117
2013
Q2 		$3.95M Buy
+96,312
New +$4.13M 0.11% 316

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Oxford Asset Management's CRL Position: Q4 2025 in Review

Oxford Asset Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 2,504 shares — an estimated $392K sold.

Oxford Asset Management first reported a position in CRL in Q2 2013 and held it in 24 quarters. The position peaked at $9.28M in Q4 2013. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Oxford Asset Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 2,504 Charles River Laboratories shares in Q4 2025, an estimated $392K.
  • Oxford Asset Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 24 quarters.
  • Oxford Asset Management's Charles River Laboratories position peaked at $9.28M in Q4 2013.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.